P330 Inflammatory Bowel Disease (IBD) patients frequently report adverse drug reactions during biologic therapy: A multicentre, prospective, patient-reported pharmacovigilance monitoring system

Published on Jan 15, 2020in Journal of Crohn's and Colitis8.658
· DOI :10.1093/ECCO-JCC/JJZ203.459
Pepijn W. A. Thomas1
Estimated H-index: 1
(Radboud University Nijmegen),
Rachel West6
Estimated H-index: 6
+ 5 AuthorsFrank Hoentjen16
Estimated H-index: 16
(Radboud University Nijmegen)
Sources
Abstract
📖 Papers frequently viewed together
10 Citations
7 Citations
15 Citations
References0
Newest
Cited By1
Newest
#1Robyn Laube (Macquarie University)H-Index: 4
#2Christian P. Selinger (University of Leeds)H-Index: 25
Source